Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research
Pillser
Search
Sign UpLog In

Bifidobacterium breve for Belly Fat: Effectiveness and Dosage

A user asked about Bifidobacterium breve's effectiveness for reducing belly fat and the required dosage. The assistant cited one study showing a beneficial effect on visceral fat, a 2026 review supporting the strain, and typical dosage of 10–50 billion CFU daily for 12+ weeks. The evidence is promising but limited.

  • Is Bifidobacterium breve effective for reducing belly fat, and how much would you need to take to see results?

  • Based on the research available through Pillser's database, there is evidence suggesting that Bifidobacterium breve may be effective for reducing visceral (belly) fat.

    Effectiveness for Belly Fat

    Pillser's research database contains 1 study on Bifidobacterium breve and reduced visceral fat, which showed a beneficial effect1. A 2026 critical review of human clinical trials found that Bifidobacterium breve, among other probiotic strains, is "consistently associated with reductions in visceral fat, total body fat, waist circumference (WC), and body fat percentage"2.

    It's worth noting that Bifidobacterium breve has also been studied for other outcomes that may indirectly relate to metabolic health, such as improved homeostasis and increased short-chain fatty acid production (both with 1 beneficial study each)1.

    Recommended Dosing

    While the Pillser research database doesn't include specific dosing information in the search results, based on the available clinical literature on the well-studied Bifidobacterium breve B-3 strain:

    • Typical dosage: 10 billion to 50 billion CFU (colony-forming units) per day.
    • Duration: Studies showing effects on body composition have typically lasted 12 weeks or longer.
    • Form: It's commonly taken in capsule or powder form.

    Several factors can influence results, including your baseline diet, overall calorie balance, physical activity levels, and the specific strain of Bifidobacterium breve used.

    Bottom Line

    The evidence is promising but limited — only 1 study with human data is currently cataloged on Pillser for this specific outcome. You can view the full details on Pillser's Bifidobacterium breve research page and the visceral fat outcome page. As with any supplement, it's best to consult with a healthcare professional before starting a new regimen.

    Footnotes

    1. Pillser research database, Bifidobacterium breve and Reduced Visceral Fat. ↩ ↩2

    2. "Anti-obesity effects of probiotics beyond BMI: a critical review of human clinical trials" (2026), Pillser research paper. ↩

New Topic

Browse Related Questions

Back to top